Kevin Eisenfrats is the founder of Contraline. Contraline has raised $25M in total funding. Latest round: Series B. Based in Charlottesville, USA.
Kevin Eisenfrats is the CEO and co-founder of Contraline, a biotechnology company focused on male reproductive health and male contraception. He is a first-time entrepreneur who has led Contraline from initial concept into a clinical-stage enterprise.
Full founder directory · Investor directory · Company funding database · Fundraising library